Nuri Karadurmuş

First-Line Camizestrant for Emerging <i>ESR1</i> -Mutated Advanced Breast Cancer

François‐Clément Bidard, Erica L. Mayer, Yeon Hee Park et al. · New England Journal of Medicine · 2025 · 110 citations · Full text

Medicine, Oncology, Pharmacology +16

Final Results of RIGHT Choice: Ribociclib Plus Endocrine Therapy Versus Combination Chemotherapy in Premenopausal Women With Clinically Aggressive Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer

Yen‐Shen Lu, Eznal Izwadi Bin Mohd Mahidin, Hamdy A. Azim et al. · Journal of Clinical Oncology · 2024 · 79 citations · Full text

Medicine, Oncology, Pharmacology +17

Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience

Hüseyin Saffet Beköz, Nuri Karadurmuş, S. Paydaş et al. · Annals of Oncology · 2017 · 69 citations · Full text

Medicine, Oncology, Pharmacotherapy +11

The Effect of Primary Surgery in Patients with De Novo Stage IV Breast Cancer with Bone Metastasis Only (Protocol BOMET MF 14-01): A Multi-Center, Prospective Registry Study

Atilla Soran, Lütfi Doğan, Serdar Özbaş et al. · Annals of Surgical Oncology · 2021 · 67 citations

Medicine, Oncology, Surgery +14

Mean platelet volume and its relationship with carotid atherosclerosis in subjects with non-alcoholic fatty liver disease

Halil Genç, Serkan Tapan, Fatih Örs et al. · Upsala Journal of Medical Sciences · 2010 · 64 citations · Full text

Medicine, Hematology, Clinical Cardiology +10